ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir.

June 23, 2006

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011

Finasteride Could Save Many Years Of Life If Widely Used For Prostate Cancer Prevention

February 25, 2005

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

Biology Societies Recomend 15% Funding Increase for NIH

February 12, 1999

Bush Budget Proposal a $511 Million Cut For NIH.

February 9, 2007